Paushak Limited (532742) Fair Value & Analysis
Other · IN · Market cap ₹11.5B
Fair value as of: Jul 4, 2026
From 16 valuation models · updated today
Share price +9.3% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹345.60 – ₹959.65 · fair‑value band ₹179.08 – ₹322.69 · the ₹545.15 price screens above the ₹250.89 fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Paushak Limited (532742) currently trades at ₹545.15, while our model-based Fair Value estimate is ₹250.89 — implying the stock looks roughly 54.0% overvalued today. We read business quality at 46/100 (below-average quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Paushak Limited generated revenue of ₹1.3B at a net margin of 24.8%. Revenue declined 13.9% year over year. It earns a return on equity of 14.8%. Net debt stands at ₹769M. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
Paushak Limited develops, manufactures, and sells phosgene based specialty chemicals and intermediates in India and internationally. Its products include isocyanates, chloroformates, carbonates/carbamates, carbamoyl chlorides, and others. The company primarily serves pharma, agro, and specialty chemical companies. Paushak Limited was incorporated in 1972 and is based in Vadodara, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Paushak Limited reported revenue of ₹2.2B in FY2026 versus ₹1.5B in FY2022, a compound +9.9%/yr. Reported net income was ₹393M in FY2026, compounding +1.1%/yr from FY2022.
Is 532742 fairly valued? → Check now
Similar stocks
6 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| There MOH | €521.90 | €269.92 | -48% |
| Sony Corporation SON1 | €17.58 | €37.56 | +114% |
| Federal Home Loan Mortgage Corporation FREJO | $16.84 | $64.93 | +286% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹279.60 | -81% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
Explore undervalued stocks
Frequently asked questions
Is Paushak Limited (532742) undervalued?
What is the fair value of 532742?
What is the quality score of 532742?
What is the revenue of Paushak Limited (532742)?
What is the net profit margin of 532742?
Does Paushak Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.